Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel S Lentz

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Gynecologic Oncology|July 30, 2002
Endometrial carcinoma diagnosed by positron emission tomography: a case reportSamuel S Lentz
The Journal of Reproductive Medicine|February 26, 2005
Transvaginal repair of the posthysterectomy vesicovaginal fistula using a peritoneal flap: the gold standardSamuel S Lentz
Gynecologic Oncology|April 16, 2003
A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group studyMark A Hoffman, John A Blessing, Samuel S Lentz, et al.
Urology Case Reports|September 27, 2023
Transvaginal ureteroneocystostomyLaurel K Berry, Collin M McKenzie, Samuel S Lentz
Cancer|October 10, 2003
Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma: a gynecologic oncology group studyDavid Scott Miller, John A Blessing, Samuel S Lentz, et al.
Gynecologic Oncology|December 7, 2002
A phase II trial of topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: a gynecologic oncology group studyDavid Scott Miller, John A Blessing, Samuel S Lentz, et al.
Gynecologic Oncology|May 15, 2007
Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinomaSamuel S Lentz, Brigitte E Miller, Gregory L Kucera, et al.
Gynecologic Oncology|September 19, 2003
Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group studyJ Tate Thigpen, John A Blessing, George Olt, et al.
Gynecologic Oncology|June 12, 2003
Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group studyAllan Covens, Virginia L Brunetto, Maurie Markman, et al.
Gynecologic Oncology|January 31, 2004
Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group studyJames V Fiorica, Virginia L Brunetto, Parviz Hanjani, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology|July 30, 2002
Endometrial carcinoma diagnosed by positron emission tomography: a case reportSamuel S Lentz
The Journal of Reproductive Medicine|February 26, 2005
Transvaginal repair of the posthysterectomy vesicovaginal fistula using a peritoneal flap: the gold standardSamuel S Lentz
Gynecologic Oncology|April 16, 2003
A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group studyMark A Hoffman, John A Blessing, Samuel S Lentz, et al.
Urology Case Reports|September 27, 2023
Transvaginal ureteroneocystostomyLaurel K Berry, Collin M McKenzie, Samuel S Lentz
Cancer|October 10, 2003
Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma: a gynecologic oncology group studyDavid Scott Miller, John A Blessing, Samuel S Lentz, et al.
Gynecologic Oncology|December 7, 2002
A phase II trial of topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: a gynecologic oncology group studyDavid Scott Miller, John A Blessing, Samuel S Lentz, et al.
Gynecologic Oncology|May 15, 2007
Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinomaSamuel S Lentz, Brigitte E Miller, Gregory L Kucera, et al.
Gynecologic Oncology|September 19, 2003
Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group studyJ Tate Thigpen, John A Blessing, George Olt, et al.
Gynecologic Oncology|June 12, 2003
Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group studyAllan Covens, Virginia L Brunetto, Maurie Markman, et al.
Gynecologic Oncology|January 31, 2004
Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group studyJames V Fiorica, Virginia L Brunetto, Parviz Hanjani, et al.
Pageof 3